Pravafenix 40 mg/160 mg hard capsules
ROFE-III-24-1
Phase 3 small_molecule active
Quick answer
Pravafenix 40 mg/160 mg hard capsules for Dyslipidaemia is a Phase 3 program (small_molecule) at Laboratoire HRA Pharma with 1 ClinicalTrials.gov record(s).
Program details
- Company
- Laboratoire HRA Pharma
- Indication
- Dyslipidaemia
- Phase
- Phase 3
- Modality
- small_molecule
- Status
- active